Web Stats Provided By Google Analytics

Sunday, February 2, 2014

At $84,000, new Gilead drug sets off payer revolt

As Gilead Sciences touted its $1,000-a-pill hepatitis C cure to investors in a hotel ballroom in San Francisco last week, a group of about 20 protesters milled outside.

http://ift.tt/1i7hQsJ
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)